MovePainFall - multicomponent exercise and pain science education for fall prevention in Community-Dwelling older adults with chronic musculoskeletal pain: a pilot randomised controlled feasibility trial
NCT ID NCT07889024
First seen Oct 22, 2026 · Last updated Oct 23, 2026 · Updated 1 time
Summary
Chronic musculoskeletal pain is common in older adults and is associated with reduced mobility, loss of function, poorer quality of life, fear of movement, fear of falling and a higher risk of falls. Exercise programmes are effective in preventing falls, but very few programmes combine fall-prevention exercise with pain self-management, including pain science education, for older people who live in the community and have both chronic pain and an increased risk of falling. The goal of this pilot randomised controlled feasibility trial is to find out whether it is feasible, acceptable and safe to deliver a 12-week supervised group programme (MovePainFall) that combines multicomponent exercise with pain science and fall-prevention education, compared with a control group that maintains usual activities, in community-dwelling adults aged 65 years or over with chronic musculoskeletal pain (lasting 3 months or more). The main questions it aims to answer are: * Is it feasible to recruit, randomise, retain and engage participants (recruitment rate, eligibility, adherence, retention) and is the programme safe and acceptable? * What are the preliminary effects of the programme on mobility, balance, lower-limb strength, dual-task performance, pain intensity and interference, fear of falling, fear of movement and quality of life? Researchers will compare the MovePainFall group with the control group to estimate feasibility parameters and preliminary effect sizes that will inform the design and sample size of a future full-scale randomised controlled trial. Participants in the MovePainFall group will: * attend three supervised 60-minute group exercise sessions per week for 12 weeks (warm-up, strength and power, challenging balance, motor-cognitive dual-task training, functional gait and daily-living tasks, relaxation); * attend one additional 30-45-minute group education session per week on pain neuroscience, pain self-management and fall prevention. Participants in the control group will maintain their usual activities and routine health care and may be invited to attend the programme after the post-intervention assessment (waiting list). All participants will be assessed by blinded assessors before randomisation and after the 12-week intervention period.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Nov 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged 65 years or over. * Living in the community (not institutionalised). * Chronic musculoskeletal pain lasting 3 months or more. * Able to walk independently, with or without a walking aid. * Able to understand and sign the informed consent form. Exclusion Criteria: * Significant neurological disease affecting mobility. * Unstable cardiovascular or metabolic conditions. * Severe cognitive impairment preventing understanding of instructions or safe participation. * Any medical contraindication to safe exercise participation (a complementary medical opinion will be requested whenever necessary to confirm eligibility and safety). * Concurrent participation in another supervised exercise programme.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Accidental falls are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
School of Education, Universidade Politécnica de Bragança (+Idade +Saúde community programme)
Bragança, Campus de Santa Apolónia, 5300-253, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does chronic pain change over time in children with duchenne muscular dystrophy?
- Prospective comparative study of the efficacy of acupuncture versus conventional treatment for the management of chronic pain in patients with chronic kidney disease receiving conservative treatment or renal replacement therapy (Peritoneal dialysis or hemodialysis)
- Wearable biofeedback devices for remote physiotherapy and rehabilitation for elderly patients suffering from arthritis and fibromyalgia
- Transcranial magnetic stimulation (TMS) for pain associated with chronic fatigue Syndrome/Primary fibromyalgia, long COVID and post-vaccination syndromes, post-stroke pain, and non-nociceptive pain
- The effect of Whole-Body Point-of-Care ultrasonography on emergency department management of patients aged 65 years and older presenting with a Ground-Level fall
- Cannabidiol pharmacotherapy for co-occurring opioid use disorder and chronic pain